Long-Term Survival Outcomes in Belatacept-Treated vs. Cyclosporine-Treated Patients: Final Results From BENEFIT-EXT

被引：0

作者：

Florman, S. ^{[1
]}

Bray, R. ^{[2
]}

Gebel, H. ^{[2
]}

Kuypers, D. ^{[3
]}

Larsen, C. ^{[2
]}

Medina Pestana, J. ^{[4
]}

Rial, M. ^{[5
]}

Rostaing, L. ^{[6
]}

Wekerle, T. ^{[7
]}

Grannas, G. ^{[8
]}

Meier-Kriesche, U. ^{[9
]}

Polinsky, M. ^{[9
]}

Townsend, R. ^{[9
]}

Munier, S. ^{[9
]}

Grinyo, J. ^{[10
]}

Durrbach, A. ^{[11
]}

机构：

[1] Mt Sinai Med Ctr, New York, NY 10029 USA

[2] Emory Univ, Atlanta, GA 30322 USA

[3] Univ Hosp Leuven, Leuven, Belgium

[4] Hosp Rim, Sao Paulo, Brazil

[5] Inst Nefrol, Buenos Aires, DF, Argentina

[6] Univ Hosp, Toulouse, France

[7] Med Univ Vienna, Vienna, Austria

[8] Hannover Med Sch, D-30623 Hannover, Germany

[9] Bristol Myers Squibb, Lawrenceville, NJ USA

[10] Univ Hosp Bellvitge, Barcelona, Spain

[11] Univ Hop Bicetre, Villejuif, France

来源：

AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷

关键词：

D O I：

暂无

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

P-45

引用

页码：45 / 45

页数：1

共 50 条

[21] Long-Term Extension of the Belatacept BENEFIT-EXT Study: Results at Month 48
Grinyo, J.
Florman, S.
Medina Pestana, J. O.
del Carmen Rial, M.
Muehlbacher, F.
Durrbach, A.
Vincenti, F.
Harler, M. B.
Duan, T.
Rostaing, L.
TRANSPLANTATION, 2012, 94 (10) : 974 - 974
[22] LONG-TERM EXTENSION OF THE BELATACEPT BENEFIT-EXT STUDY: RESULTS AT MONTH 48
Grinyo, J.
Florman, S.
Medina, J.
Rial, M. Del C.
Muhlbacher, F.
Durrbach, A.
Vincenti, F.
Harler, M. B.
Duan, T.
Rostaing, L.
TRANSPLANT INTERNATIONAL, 2012, 25 : 24 - 24
[23] BELATACEPT-TREATED PATIENTS HAD SUPERIOR ESTIMATED GLOMERULAR FILTRATION RATE VERSUS CYCLOSPORINE-TREATED PATIENTS: RESULTS FROM A MIXED EFFECTS MODELING ANALYSIS OF BENEFIT
Grinyo, J.
Rostaing, L.
Bresnahan, B.
Rice, K.
Vincenti, F.
Munier, S.
Polinsky, M.
Meier-Kriesche, U.
Reyes-Acevedo, R.
Medina Pestana, J.
TRANSPLANT INTERNATIONAL, 2015, 28 : 51 - 51
[24] 4-Year Results from the Long-Term Extension of the Belatacept BENEFIT-EXT Study
Florman, S.
Durrbach, A.
Grinyo, J.
Pestana, J. O. M.
Rial, M. d. C.
Vitko, S.
Lin, C. -S.
Harler, M. B.
Rostaing, L.
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 82 - 82
[25] FOUR-YEAR OUTCOMES BY DONOR TYPE FROM THE LONG-TERM EXTENSION OF THE BELATACEPT BENEFIT AND BENEFIT-EXT STUDIES
Durrbach, A.
Medina Pestana, J.
Becker, T.
Grinyo, J.
Lang, P.
Garcia, V. D.
Duan, T.
Florman, S.
TRANSPLANT INTERNATIONAL, 2012, 25 : 50 - 50
[26] Four-Year Outcomes by Donor Type from the Long-Term Extension of the Belatacept BENEFIT and BENEFIT-EXT Studies
Durrbach, A.
Medina Pestana, J.
Becker, T.
Grinyo, J.
Lang, P.
Garcia, V. D.
Agarwal, M.
Duan, T.
Florman, S.
TRANSPLANTATION, 2012, 94 (10) : 987 - 987
[27] Belatacept vs Cyclosporine in ECD Kidney Transplants: Two-Year Outcomes from the BENEFIT-EXT Study
Durrbach, A.
Larsen, C. P.
Pestana, J. Medina
Vanrenterghem, Y.
Vincenti, F.
Florman, S.
Xing, J.
Block, A.
Garg, P.
Grinyo, J.
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 83 - 83
[28] BELATACEPT VS CYCLOSPORINE IN ECD KIDNEY TRANSPLANTS: TWO-YEAR OUTCOMES FROM THE BENEFIT-EXT STUDY
Durrbach, A.
Larsen, C.
Medina Pestana, J.
Vanrenterghem, Y.
Vincenti, F.
Florman, S.
Xing, J.
Block, A.
Garg, P.
Grinyo, J.
TRANSPLANT INTERNATIONAL, 2010, 23 : 59 - 59
[29] RENAL FUNCTION IN PATIENTS TREATED WITH BELATACEPT-OR CYCLOSPORINE-BASED REGIMENS AT YEAR 3 IN THE BENEFIT AND BENEFIT-EXT STUDIES
Durrbach, Antoine
Citterio, Franco
Mulloy, Laura
David-Neto, Elias
Russ, Graeme
Vitko, Sefan
Zhang, Rubin
Xing, Jun
Harler, Mary Beth
Grinyo, Josep
TRANSPLANT INTERNATIONAL, 2011, 24 : 249 - 249
[30] LONG-TERM OUTCOMES IN EPSTEIN-BARR VIRUS POSITIVE (EBV plus ) PATIENTS RECEIVING BELATACEPT (BELA) OR CYCLOSPORINE (CSA) IN BENEFIT-EXT
Florman, S.
Medina Pestana, J.
Rial, M. Del C.
Rostaing, L.
Kuypers, D.
Matas, A.
Wekerle, T.
Grinyo, J.
Meier-Kriesche, U.
Polinsky, M.
Zhao, H.
Durrbach, A.
TRANSPLANT INTERNATIONAL, 2017, 30 : 7 - 7

← 1 2 3 4 5 →